Advertisement

Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal
This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more
- Evaxion Announces Closing of $10.8m Public Offering (2025-01-31)
Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing of a public offering of an aggregate of 3,997,361 of its American Depositary Shares (“AD... - Medix Biochemica Oy Acquires Candor Bioscience GmbH (2025-01-22)
> Medix Biochemica acquires CANDOR Bioscience, a leading provider of premium immunoassay solutions, based in Wangen, Germany. > The acquisition strengthens Medix Biochemica’s portfolio in critical raw materials for in vitro diagnostics (IVD) and enhances its ... - Arctic Therapeutics Closes €26.5m Series A Financing (2025-01-22)
> Funding will accelerate the company's anti-amyloid treatment for rare and common forms of dementia. > As well as bringing forward a new class of treatment for inflammatory skin diseases. > Sanos Group CEO Jeppe Ragnar Andersen joins the board. Icelandi... - Circio & 4basebio Partner for circVec Synthetic DNA Vectors (2025-01-21)
> 4basebio and Circio are combining Circio´s circVec circular RNA expression system with 4basebio´s proprietary synthetic DNA formats hpDNA™ and opDNA™ > 4basebio´s unique nanoparticle delivery platform, Hermes™, allows for improved delivery of syntheti... - bioMérieux to Acquire Remaining 80% of SpinChip for €111m (2025-01-13)
bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire SpinChip Diagnostics ASA (“SpinChip”), a privately held Norwegian diagnostics company that has developed a game-changing immunoassay dia... - Windward Bio: $200m Series A & License to TSLP Ab from China (2025-01-10)
> Highly experienced management team with a successful track record in advancing compounds from target identification to commercialization > Top-tier global investors fund the company through clinical proof of concept of its lead program and IND-enablement of bi... - Numab Therapeutics Closes CHF50m Series C Extension (2025-01-09)
> CHF 50 Million extension round co-led by Cormorant Asset Management, with participation from other existing investors > Proceeds will be used to support the advancement of multiple first-in-class and best-in-class programs into clinical development Numa... - Coave Tx: €32m Series A Led by Novo Holdings & Bpifrance (2025-01-09)
> Financing co-led by Novo Holdings A/S and Bpifrance (as part of the InnoBio investment strategy) and joined by leading US and EU investors Invus and UI Investissement alongside existing investors > Proceeds to advance Coave’s proprietary ALIGATER™ platform... - Inverna Therapeutics Launched by Argobio and Univ Odense (2025-01-07)
Inverna Therapeutics, a novel Danish biotech company at the forefront of innovative RNA therapeutics, today announced its launch as a leading-edge RNA therapeutics company. The Company was co-founded by the University of Southern Denmark and Argobio and is dedicat... - Orbis Medicines ApS Raises €90m Series A Led by NEA (2025-01-06)
> Funding to support the development of pipeline of oral macrocycle drugs, called ‘nCycles,’ focused on validated blockbuster biologic targets > Orbis’ nGen platform systematically explores oral macrocycle design with automated chemistry and machine learni...
Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!
[LSS] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!
» Start here with the latest News!Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top